Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$4.76B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.4B |
| 4 |
Amazon
AMZN
|
+$1.22B |
| 5 |
Broadcom
AVGO
|
+$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Baytex Energy
BTE
$1.83B
| $1.01M | ﹤0.01% |
337,705
-429,645
| -56% | -$1.29M |
|
3352
Ambev
ABEV
$35.7B
| $1.01M | ﹤0.01% |
414,123
-60,313
| -13% | -$147K |
|
3353
Expensify
EXFY
$174M
| $1.01M | ﹤0.01% |
514,948
+52,385
| +11% | +$103K |
|
|
MRNS
3354
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1M | ﹤0.01% |
568,517
-48,878
| -8% | -$86.1K |
|
3355
Travelzoo
TZOO
$103M
| $991K | ﹤0.01% |
82,241
+7,857
| +11% | +$94.7K |
|
3356
Laser Photonics
LASE
$37.3M
| $989K | ﹤0.01% |
60,656
+21,106
| +53% | +$344K |
|
3357
M-tron Industries
MPTI
$142M
| $989K | ﹤0.01% |
23,706
+3,718
| +19% | +$155K |
|
3358
Riverview Bancorp
RVSB
$101M
| $988K | ﹤0.01% |
209,781
+5,551
| +3% | +$26.2K |
|
3359
Relmada Therapeutics
RLMD
$53.4M
| $987K | ﹤0.01% |
304,502
+44,004
| +17% | +$143K |
|
3360
Comp X International
CIX
$282M
| $984K | ﹤0.01% |
33,674
+265
| +0.8% | +$7.74K |
|
3361
Grifois
GRFS
$6.7B
| $982K | ﹤0.01% |
110,532
+39,733
| +56% | +$353K |
|
|
IVAC
3362
DELISTED
Intevac Inc
IVAC
| $977K | ﹤0.01% |
287,163
+8,063
| +3% | +$27.4K |
|
3363
Aclaris Therapeutics
ACRS
$213M
| $974K | ﹤0.01% |
846,446
+72,309
| +9% | +$83.2K |
|
3364
GoHealth
GOCO
$75.9M
| $973K | ﹤0.01% |
103,735
+3,205
| +3% | +$30.1K |
|
3365
LivePerson
LPSN
$91.8M
| $961K | ﹤0.01% |
750,595
-81,036
| -10% | -$104K |
|
|
ACR
3366
ACRES Commercial Realty
ACR
$156M
| $961K | ﹤0.01% |
61,346
-11,455
| -16% | -$179K |
|
|
CKPT
3367
DELISTED
Checkpoint Therapeutics
CKPT
| $958K | ﹤0.01% |
427,651
+124,787
| +41% | +$280K |
|
3368
inTEST
INTT
$88.6M
| $957K | ﹤0.01% |
131,106
+8,161
| +7% | +$59.6K |
|
|
NNE
3369
Nano Nuclear Energy
NNE
$1.37B
| $954K | ﹤0.01% |
+66,224
| New | +$954K |
|
3370
CytomX Therapeutics
CTMX
$345M
| $948K | ﹤0.01% |
803,531
+34,032
| +4% | +$40.2K |
|
3371
NeoVolta
NEOV
$154M
| $947K | ﹤0.01% |
306,324
+15,427
| +5% | +$47.7K |
|
3372
Eledon Pharmaceuticals
ELDN
$155M
| $942K | ﹤0.01% |
378,058
+33,569
| +10% | +$83.6K |
|
3373
Citius Pharmaceuticals
CTXR
$20.4M
| $941K | ﹤0.01% |
75,158
+9,306
| +14% | +$116K |
|
3374
OPAL Fuels
OPAL
$63.5M
| $940K | ﹤0.01% |
257,549
+41,250
| +19% | +$151K |
|
3375
CSP Inc
CSPI
$108M
| $934K | ﹤0.01% |
71,886
-720
| -1% | -$9.36K |
|